CASTLE BIOSCIENCES, INC. (CSTL) FY2026 Q2 P&L / Income Statement

CASTLE BIOSCIENCES, INC. (CSTL) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

NET REVENUES

103,546,000 US dollars

Operating expenses (calculated)

106,616,000 US dollars

Operating loss

negative 3,070,000 US dollars

Other income (expense), net (calculated)

1,380,000 US dollars

Loss before income taxes

negative 1,690,000 US dollars

Income tax expense (benefit)

370,000 US dollars

Net (loss) income

negative 2,060,000 US dollars

Dermatologic

48,704,000 US dollars

Non-Dermatologic

54,842,000 US dollars

Total operating expenses, net

106,616,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.